Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 9, 2016, Pages 1345-1346

  Stefan, Norbert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMETABOLIC DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; EDITORIAL; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MORBID OBESITY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PREVALENCE; CORONARY ARTERY DISEASE;

CORONARY ARTERY DISEASE; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84996946689     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.05.025     Document Type: Editorial

References (24)

1. 1 Williams, C.D., Stengel, J., Asike, M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140 (2011), 124–131.
2. 2 Ahmed, A., Wong, R.J., Harrison, S.A., Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes. Clin Gastroenterol Hepatol 13 (2015), 2062–2070.
3. 3 Pais, R., Lebray, P., Rousseau, G., et al. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. Clin Gastroenterol Hepatol 13 (2015), 992–999.e2.
4. 4 Mittal, S., El-Serag, H.B., Sada, Y.H., et al. Hepatocellular carcinoma in the absence of cirrhosis in United States Veterans is associated with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 14 (2016), 124–131.e1.
5. 5 Chalasani, N., Younossi, Z., Lavine, J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142 (2012), 1592–1609.
6. 6 Cohen, J.C., Horton, J.D., Hobbs, H.H., Human fatty liver disease: old questions and new insights. Science 332 (2011), 1519–1523.
7. 7 Stefan, N., Häring, H.U., Hu, F.B., et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1 (2013), 152–162.
8. 8 Stefan, N., Fritsche, A., Schick, F., Häring, H.U., Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol, 2016 [Epub ahead of print].
9. 9 Saltiel, A.R., Kahn, C.R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001), 799–806.
10. 10 Targher, G., Day, C.P., Bonora, E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363 (2010), 1341–1350.
11. 11 Shulman, G.I., Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 371 (2014), 1131–1141.
12. 12 Stefan, N., Haring, H.U., The role of hepatokines in metabolism. Nat Rev Endocrinol 9 (2013), 144–152.
13. 13 Stefan, N., Haring, H.U., Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19 (2013), 394–395.
14. 14 Jacobs, K., Brouha, S., Bettencourt, R., et al. Association of nonalcoholic fatty liver disease with visceral adiposity but not coronary artery calcification in the elderly. Clin Gastroenterol Hepatol 14 (2016), 1337–1344.
15. 15 Goossens, N., Hoshida, Y., Song, W.M., et al. Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery. Clin Gastroenterol Hepatol 14 (2016), 1337–1344.
16. 16 Arulanandan, A., Ang, B., Bettencourt, R., et al. Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 13 (2015), 1513–1520.e1.
17. 17 Assy, N., Djibre, A., Farah, R., et al. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 254 (2010), 393–400.
18. 18 Chen, C.H., Nien, C.K., Yang, C.C., et al. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci, 55, 2010, 1752e60.
19. 19 Kim, D., Choi, S.Y., Park, E.H., et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology, 56, 2012, 605e13.
20. 20 Liu, J., Musani, S.K., Bidulescu, A., et al. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 224 (2012), 521–525.
21. 21 Mellinger, J.L., Pencina, K.M., Massaro, J.M., et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. J Hepatol 63 (2015), 470–476.
22. 22 Oni, E.T., Agatston, A.S., Blaha, M.J., et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?. Atherosclerosis 230 (2013), 258–267.
23. 23 Sung, K.C., Ryu, S., Lee, J.Y., et al. Fatty liver, insulin resistance, and obesity: relationships with increase in coronary artery calcium over time. Clin Cardiol, 2016 Epub ahead of print.
24. 24 Schwenzer, N.F., Springer, F., Schraml, C., et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51 (2009), 433–445.